Diarrhea-predominant Irritable Boewl Syndrome
2 clinical trials · Condition
◉ Watch Diarrhea-predominant Irritable Boewl Syndrome
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Changkang Granules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver qi Affecting the Spleen Pattern) (NCT06753890) | Tasly Pharmaceutical Group Co., Ltd | 2024-12-30 |
| Efficacy and Safety of Modified Gegen Qinlian Decoction for Diarrhea-predominant Irritable Boewl Syndrome (NCT04312477) | Xiyuan Hospital of China Academy of Chinese Medical Sciences | 2019-04-01 |
Track Diarrhea-predominant Irritable Boewl Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.